Wordt geladen...
Genomic and transcriptomic profiling expands precision cancer medicine: the WINTHER trial
Precision medicine focuses on DNA abnormalities, but not all tumors have tractable genomic alterations. The WINTHER trial (NCT01856296) navigated patients to therapy on the basis of fresh biopsy-derived DNA sequencing (arm A; 236 gene panel) or RNA expression (arm B; comparing tumor to normal). The...
Bewaard in:
| Gepubliceerd in: | Nat Med |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , , , , , , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2019
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6599610/ https://ncbi.nlm.nih.gov/pubmed/31011205 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-019-0424-4 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|